Ortho Regenerative Technologies Inc. announced the appointment of Patrick O'Donnell to its Board of Directors, effective immediately. The company also announced the retirement of Prof Michael Buschmann and Prof. Caroline Hoemann from its Board of Directors, effective February 22, 2021. Prof Buschmann and Prof Hoemann have both provided the company with more than five years of scientific leadership as company founders, inventors, Board members and as members of the Scientific Advisory Board ("SAB"). Patrick O'Donnell is the President and Chief Executive Officer of HD LifeSciences, a prominent life sciences executive with over 25 years of experience guiding companies in both the pre-commercial and commercial stages. Mr. O'Donnell brings a comprehensive understanding of the medical device, orthobiologics and biomaterial industries in the orthopedic, spine, neurosurgery, and sports medicine markets.